The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration

Bone Marrow Transplantation

Volumn 40, Issue 5, 2007, Pages 457-460

  Nihtinen, A ^a   Anttila, V J ^a   Richardson, M ^b   Meri, T ^b   Volin, L ^a   Ruutu, T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; AIR SAMPLING; AIRBORNE PARTICLE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ATMOSPHERIC PRESSURE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONSTRUCTION WORK; DRUG MEGADOSE; DUST; ENVIRONMENTAL MONITORING; FILTER; FILTRATION; FOLLOW UP; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MOULD; MOUTH CAVITY; MULTIPLE MYELOMA; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; ROOM VENTILATION; WARD;

AIR MICROBIOLOGY; AIR POLLUTION, INDOOR; ASPERGILLOSIS; DISEASE OUTBREAKS; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; FACILITY DESIGN AND CONSTRUCTION; FUNGI; HOSPITAL UNITS; HUMANS; PARTICULATE MATTER; STEM CELL TRANSPLANTATION; VENTILATION;

EID: 34548068372     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705749     Document Type: Article

References (26)

1. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466.
2. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34: 909-917.
3. Jantunen E, Nihtinen A, Volin L, Juvonen E, Parkkali T, Ruutu T et al. Candidaemia in allogeneic stem cell transplant recipients: Low risk without fluconazole prophylaxis. Bone Marrow Transplant 2004; 34: 891-895.
4. Herbrecht R, Denning DW, Patterson TF, Bennet JE, Greene RE, Oestman JW et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
5. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G, Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hopitaux de Paris. Epidemiology of invasive aspergillosis in France: A six-year multicentric survey in the greater Paris area. J Hosp Infect 2002; 51: 288-296.
6. Shaukat A, Bakri F, Young P, Hahn T, Ball D, Baer MR et al. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics. Mycopathologia 2005; 159: 181-188.
7. Leenders AC, van Belkum A, Behrendt M, Luijendijk A, Verbrugh HA. Density and molecular epidemiology of aspergillus in air and relationship to outbreaks of aspergillus infection. J Clin Microbiol 1999; 37: 1752-1757.
8. Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001; 66: 257-262.
9. Rhame FS. Prevention of nosocomial aspergillosis. J Hosp Infect 1991; 18 (Suppl A): 466-472.
10. Sarubbi FA, Kopf HB, Wilson MB, McGinnis MR, Rutala WA. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982, 125: 33-38.
11. Arnow PM, Sadigh M, Costas C, Weil D, Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of aspergillus organisms. J Infect Dis 1991; 164: 998-1002.
12. Thio CL, Smith D, Merz WG, Streifel AJ, Bova G, Gay L et al. Refinements of envirorimental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 2000; 21: 18-23.
13. Vonberg R-P, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006; 63: 246-254.
14. Ruutu P, Valtonen V, Tiitanen L, Elonen E, Volin L, Veijalainen P et al. An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis 1987; 19: 347-351.
15. Cornet M, Levy V, Fleury L, Lortholary J, Barquins S, Coureul MH et al. Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 1999; 20: 508-513.
16. Berthelot P, Loulergue P, Raberin H, Turco M, Mounier C, Tran Manh Sung R et al. Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards. Clin Microbiol Infect 2006; 12: 738-744.
17. Overberger PA, Wadowsky RM, Schaper MM. Evaluation of airborne particulates and fungi during hospital renovation. Am Ind Hyg Assoc J 1995; 56: 706-712.
18. Humphreys H, Johnson EM, Warnock DW, Willatts SM, Winter RJ, Speller DC. An outbreak of aspergillosis in a general ITU. J Hosp Infect 1991; 18: 167-177.
19. Alberti C, Bouakline A, Ribaud P, Lacroix C, Rousselot P, Leblanc T et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients. J Hosp Infect 2001; 48: 198-206.
20. Iwen PC, Davis JC, Reed EC, Winfield BA, Hinrichs SH. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 1994, 15: 303-306.
21. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90: 4-9.
22. Jeffery GM, Beard ME, Ikram RB, Chua J, Allen JR, Heaton DC et al. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med 1991; 90: 685-692.
23. Richardson MD, Rennie S, Marshall I, Morgan MG, Murphy JA, Shankland GS et al. Fungal surveillance of an open haematology ward. J Hosp Infect 2000; 45: 288-292.
24. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845-851.
25. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545-1552.
26. Faure O, Fricker-Hidalgo H, Lebeau B, Mallaret MR, Ambroise-Thomas P, Grillot R. Eight-year surveillance of environmental fungal contamination in hospital operating rooms and haematological units. J Hosp Infect 2002; 50: 155-160.